6 results match your criteria: "University of Western Ontario and St. Joseph's Health Care London[Affiliation]"
An Update of Outcome Measures in Systemic Sclerosis.
Arthritis Care Res (Hoboken)
October 2020
University of Western Ontario and St. Joseph's Health Care London, London, Ontario, Canada.
Would a 'Rosendo' by Another Name Smell as Sweet? Gender Disparity in Academic Rank and Publications in Rheumatology.
Arthritis Rheumatol
January 2021
University of Western Ontario and St. Joseph's Health Care London, London, Ontario, Canada.
Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort.
Arthritis Rheumatol
January 2021
University of Western Ontario and St. Joseph's Health Care London, London, Ontario, Canada.
Objective: To examine the relationship between disease activity and fatigue over time in early rheumatoid arthritis (RA).
Methods: Data were from patients with early RA (duration of symptoms ≤12 months) enrolled in the Canadian Early Arthritis Cohort (CATCH). Patients rated their fatigue over the past week using an 11-point numerical rating scale (NRS) for up to 5 years of follow-up.
Understanding antidepressant tachyphylaxis.
Pharmacol Res
March 2019
Department of Psychiatry, University of Western Ontario and St. Joseph's Health Care London Parkwood Institute, 550 Wellington Road, P.O. Box 5777, Stn B, London, ON, N6A 4V2, Canada. Electronic address:
Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
J Rheumatol
February 2019
From the Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec; University of Western Ontario and St. Joseph's Health Care London, London; Hospital for Sick Children, Toronto; University of Toronto, Toronto; Medical Affairs, GlaxoSmithKline Inc., Mississauga, Ontario; CH Maisonneuve-Rosemont, Montreal; BC Children's Hospital, Vancouver, British Columbia; McGill University Health Centre, Montreal, Quebec; Jewish General Hospital, Lady Davis Institute and McGill University, Montreal, Quebec; IWK Health Centre and Dalhousie University, Halifax, Nova Scotia; University of Ottawa, Ottawa, Ontario; Division of Rheumatology, Arthritis Research Canada, University of British Columbia; Rheumatology Clinic, Calgary, Alberta; Montreal Children's Hospital, McGill University Health Centre, Montreal; Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; GlaxoSmithKline Inc., King of Prussia, Pennsylvania, USA.
Objective: Persistent systemic lupus erythematosus (SLE) disease activity is associated with increased morbidity and mortality. In a multicenter cohort of patients with prevalent SLE, we described persistence, patterns, and predictors of change in disease activity over time.
Methods: Based on SLE Disease Activity Index (SLEDAI)-2K scores at cohort entry, patients were classified into 4 groups: low (score < 4; LOW), moderate (4 to < 6; MOD), moderately high (6 to ≤ 10; MHIGH), and very high (> 10; VHIGH).
Results from the FOOD trial.
Lancet Neurol
May 2005
Department of Physical Medicine & Rehabilitation, Schulich School of Medicine, University of Western Ontario and St Joseph's Health Care London, London, Ontario, Canada.